Gadolinium dimeglumine as a contrast agent for digital subtraction angiography: In Vitro hounsfield unit measurement and clinical efficacy

Yonsei Medical Journal

Volumn 44, Issue 1, 2003, Pages 138-142

  Kim, Man Deuk ^a   Kim, Hyun ^b  

^a Bundang CHA Hospital   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

DSA; Gadolinium; Hounsfield unit

Indexed keywords

CONTRAST MEDIUM; CREATININE; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; IODINATED CONTRAST MEDIUM; IOPROMIDE; SODIUM CHLORIDE;

ANALYTIC METHOD; ARTICLE; ARTIFICIAL EMBOLISM; BILIARY TRACT DRAINAGE; BRAIN ANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENSITY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; HEMODIALYSIS; HEMODILUTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MEASUREMENT; NEPHROTOXICITY; PERCUTANEOUS NEPHROSTOMY; RADIATION ATTENUATION; RADIOLOGICAL PARAMETERS; SYRINGE;

EID: 0037295855     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.1.138     Document Type: Article

References (11)

1. Breizis M, Epstein FH. A closer look at radiocontrast-induced nephropathy (editorial). N Engl J Med 1989;320:179-81.
2. Haustein J, Niendorf HP, Krestin G, Louton T, Schuhmann-Giampieri G, Clauss W, et al. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 1992;27:153-6.
3. John AK, Stuart CG, Arthur CW. Renal insufficiency: Gadopentetate Dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 1996;198:579-81.
4. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: A randomized trial: The Iohexol Cooperative Study. Kidney Int 1995;47:254-61.
5. Henzen C, Buess M, Brander L. Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): A current disease picture. Schweiz Med Wochenschr 1999;129:658-64.
6. Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA: results of a randomized, controlled clinical trial. Interv Radiol 1991;26 Suppl:221-3.
7. 2 digital subtraction angiography: Potential complications and their prevention. J Vasc Interv Radiol 1997;8:383-91.
8. Runback JH, Shah PM, Wong J, Babu SC, Rozenblit G, Poplausky MR. Livedo reticularis, rhabdomyolysis, massive intestinal infarction, and death after carbon dioxide arteriography. J Vasc Surg 1997;26:337-40.
9. Kieran JM, James AB, Richard HC. Adverse reactions to Gadolinium contrast media: A review of 36 Cases. AJR 1996;167:847-9.
10. Gemery J, Idelson B, Reid S, Yucel EK, Pagan-Marin H, Ali S, et al. Acute renal failure after arteriography with a Gadolinium-based contrast agent. AJR 1998;171:1277-8.
11. John AK, Stuart CG, Hasan B, Arthur CW. Gadolinium-based contrast agents as an alternative at venacavography in patients with renal insufficiency-early experience. Radiology 1999;212:280-4.